PDX

The PDX patent portfolio covers advanced methods for detecting pathogens using nucleic acid probes arranged on a three-dimensional lattice microarray. This innovative structure enhances the specificity and sensitivity of fluorescence-based detection compared to conventional microarrays. The portfolio supports improved diagnostics for bacterial and viral identification through novel array designs, providing a foundation for sensitive and accurate pathogen testing technologies.